Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments. Issue 10 (October 2015) - Laurenti, Luca
Highlights BR front-line therapy provides in elderly CLL patients a high response rate. More than 50% elderly CLL patients reduced bendamustine dose. del17 was the only unfavorable parameter for response rate and PFS.